Controversies: Nasal mass in a pediatric patient
β Scribed by James R. Reilly; Dr. Charles F. Koopman; Dr. Robin Cotton
- Publisher
- John Wiley and Sons
- Year
- 1992
- Tongue
- English
- Weight
- 362 KB
- Volume
- 14
- Category
- Article
- ISSN
- 1043-3074
No coin nor oath required. For personal study only.
β¦ Synopsis
Fortunately, few tumors that present in the newborn period are malignant. However, the mere existence of a mass in a neonate presents special concerns. What is the location of the mass? Is there involvement of vital structures? And, in the case of an intranasal mass, the question is not whether the mass is treated, but when and how?
You are called to the newborn nursery to evaluate a full term, 7 lb. 2 oz. infant who is having difficulty breathing while breast feeding. The mother and pediatrician deny stridor, apnea, or duskiness. The baby has a normal cry and no difficulty breathing at rest.
Examination reveals a fleshy, nonfriable mass in the left nares (Figure 1). The face is symmetrical, although the nasal dorsum is slightly wide. No pits or dimples are noted over the glabella. Neurologic and head and neck examinations are normal.
Readers are invited to submit particularly difficult cases for consideration to
π SIMILAR VOLUMES
## BACKGROUND. The head and neck region is one of the most common locations of rhabdomyosarcoma. Salivary gland involvement is usually secondary to advanced disease, and presentation as a primary salivary gland tumor is very rare. ## METHODS. Three cases of rhabdomyosarcoma presenting as paroti
As therapeutic apheresis becomes more and more popular, its use in children has remained limited. in most cases, the reports that do exist are either brief abstracts or a notation in a larger group of adult patients.
Thrombosis of the vena cava can occur secondary to intraabdominal disease and can be associated with abdominal pain. 1,2 Thrombosis of the major abdominal veins, including the inferior vena cava, can occur in patients with abdominal pathology, especially in the setting of genetic prothrombotic tende